Milberg Weiss Bershad Hynes & Lerach

Milberg Weiss Bershad Hynes & Lerach was a preeminent American law firm that specialized in class-action litigation, particularly in the area of securities fraud. The firm was well-known for its aggressive pursuit of corporations on behalf of shareholders, frequently targeting companies in the pharmaceutical, biotechnology, and healthcare sectors following stock price declines. At its height, it was considered the most powerful plaintiffs' firm in the United States, significantly influencing corporate governance and disclosure practices. The firm eventually collapsed following a high-profile federal investigation into a scheme involving illegal kickbacks paid to lead plaintiffs. This investigation led to the imprisonment of several name partners, including Melvyn Weiss and Bill Lerach. While not a life science company, its litigation activities were a major factor in the business environment for public biotech and pharma companies for decades.